References
- Hassani S, Hershman JM. Thyroid diseases. In: Hazzard WR, Blass JP, Et' tinger WH, et al, eds. Principles of geriatric medicine and gerontology. 4th ed. New York: McGraw-Hill, 1999: 973–89
- Tietz NW, Shuey DF, Wekstein DR. Laboratory values in fit aging individuals—sexagenarians through centenarians. Clin Chem 1992; 38(6): 1167–85
- Hershman JM, Pekary AE, Berg L, et al. Serum thyrotropin and thyroid hormone levels in elderly and middle-aged euthyroid persons. J Am Geriatr Soc 1993; 41(8): 823–8
- Olsson M, Viitanen M, Hagg E, et al. Hormones in ‘young’ and ‘old’ elderly: pituitary-thyroid and pituitary-adrenal axes. Gerontology 1989; 35(2–3): 144–52
- Mariotti S, Chiovato L, Franceschi C, et al. Thyroid autoimmunity and aging. Exp Gerontol 1998; 33(6): 535–41
- Ladenson PW, Singer PA, Ain KB, et al. American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med 2000; 160(11): 1573–5
- Helfand M, Redfern CC. Screening for thyroid disease: an update. Ann Intern Med 1998; 129(2): 144–58
- Guide to clinical preventive services: report of the US Preventive Services Task Force. 2nd ed. Baltimore: Williams and Wilkins, 1996: 209–18
- Doucet J, Trivalle C, Chassagne P, et al. Does age play a role in clinical presentation of hypothyroidism? J Am Geriatr Soc 1994; 42(9): 984–6
- Trivalle C, Doucet J, Chassagne P, et al. Differences in the signs and symptoms of hyperthyroidism in older and younger patients. J Am Geriatr Soc 1996; 44(1): 50–3
- Coll PP, Abourizk NN. Successful withdrawal of thyroid hormone therapy in nursing home patients. J Am Board Fam Pract 2000; 13(6): 403–7
- Canaris GJ, Manowitz NR, Mayor G, et al. The Colorado thyroid disease prevalence study. Arch Intern Med 2000; 160(4): 526–34
- Hak AE, Pols HA, Visser TJ, et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 2000; 132(4): 270–8
- Kahaly GJ. Cardiovascular and atherogenic aspects of subclinical hypothyroidism. Thyroid 2000; 10(8): 665–79
- Cooper DS, Halpern R, Wood LC, et al. L-Thyroxine therapy in subclinical hypothyroidism: a double-blind, placebo-controlled trial. Ann Intern Med 1984; 101(1): 18–24
- Jaeschke R, Guyatt G, Gerstein H, et al. Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism? J Gen Intern Med 1996; 11(12): 744–9
- Foldes J, Taijan G, Szathmari M, et al. Bone mineral density in patients with endogenous subclinical hyperthyroidism: Is this thyroid status a risk feetor for osteoporosis? Clin Endocrinol (Oxf) 1993; 39(5): 521–7
- Biondi B, Fazio S, Carella C, et al. Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine. J Clin Endocrinol Metab 1993; 77(2): 334–8
- Smallridge RC. Disclosing subclinical thyroid disease: an approach to mild laboratory abnormalities and vague or absent symptoms. Postgrad Med 2000; 107(1): 143–52